Emergent BioSolutions Inc (NYSE:EBS)

66.45
Delayed Data
As of 4:02pm ET
 +0.49 / +0.74%
Today’s Change
36.38
Today|||52-Week Range
67.24
+43.00%
Year-to-Date
No recent news for Emergent BioSolutions Inc.

Today’s Trading

Previous close65.96
Today’s open65.90
Day’s range65.02 - 66.92
Volume242,044
Average volume (3 months)334,796
Market cap$3.3B
Data as of 4:02pm ET, 09/24/2018

Growth & Valuation

Earnings growth (last year)+51.33%
Earnings growth (this year)+25.79%
Earnings growth (next 5 years)+15.15%
Revenue growth (last year)+14.75%
P/E ratio29.5
Price/Sales4.17
Price/Book3.57

Competitors

 Today’s
change
Today’s
% change
ARRYArray Biopharma Inc-0.58-3.79%
MDGLMadrigal Pharmaceuti...+15.76+7.46%
ICPTIntercept Pharmaceut...+3.48+3.05%
HZNPHorizon Pharma PLC+0.39+2.07%
Data as of 4:00pm ET, 09/24/2018

Financials

Next reporting dateNovember 8, 2018
EPS forecast (this quarter)$0.54
Annual revenue (last year)$560.9M
Annual profit (last year)$82.6M
Net profit margin14.73%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Daniel J. Abdun-Nabi
President &
Chief Operating Officer
Robert G. Kramer
Corporate headquarters
Gaithersburg, Maryland

Forecasts